AI assistant
Sending…
aTYR PHARMA INC — Director's Dealing 2024
Jun 3, 2024
34337_dirs_2024-06-03_e59d9abc-a09c-4560-ac37-0841216264b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: aTYR PHARMA INC (LIFE)
CIK: 0001339970
Period of Report: 2024-05-31
Reporting Person: Broadfoot Jill Marie (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-31 | Common Stock | P | 5000 | $1.79 | Acquired | 27960 | Direct |
Footnotes
F1: Includes 2,139 shares acquired on May 15, 2024 under the Company's 2015 Employee Purchase Plan.
More from aTYR PHARMA INC
Report Publication Announcement
2026
Jun 1
Interim / Quarterly Report
2026
May 15
Earnings Release
2026
May 15
Regulatory Filings
2026
May 11
Remuneration Information
2026
Mar 26
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 9